Skye Bioscience, Inc. (SKYE) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Skye Bioscience, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.786 -- 00:00:04.730 Ladies and gentlemen, thank you for standing by. 00:00:04.730 -- 00:00:07.354 My name is Jael, and I will be your conference operator today. 00:00:07.354 -- 00:00:11.860 At this time, I would like to welcome everyone to the Sky Bioscience Year End 2024 earnings 00:00:11.860 -- 00:00:15.925 call. All lines have been placed on mute to prevent any background noise. 00:00:15.925 -- 00:00:18.709 After the speaker's remarks, there will be a question and answer session. 00:00:18.709 -- 00:00:22.674 I would now like to turn the conference over to Bernie Hertel, head of investor relations. 00:00:22.674 -- 00:00:25.035 Please go ahead. 00:00:25.538 -- 00:00:28.988 Hello, and thank you all for participating in today's call. 00:00:28.988 -- 00:00:33.993 Leading the discussion today are Puneet Dhillon, SCEI's President and CEO, and Caitlin 00:00:33.993 -- 00:00:37.354 Arsenault, SCEI's CFO. 00:00:37.456 -- 00:00:41.420 Before we begin, I'd like to caution that comments made during this conference call will 00:00:41.420 -- 00:00:45.104 contain forward-looking statements under the safe harbor provisions of the U.S. 00:00:45.104 -- 00:00:49.568 Private Securities Litigation Reform Act of 1995, including 00:00:49.568 -- 00:00:54.032 statements about SCEI's expectations regarding its development activities, timelines, 00:00:54.032 -- 00:00:56.152 and milestones. 00:00:56.242 -- 00:01:00.107 Forward-looking statements are subject to risks and uncertainties that could cause actual 00:01:00.107 -- 00:01:04.872 results to differ materially and adversely, and reported results should not be considered 00:01:04.872 -- 00:01:07.836 as an indication of future performance. 00:01:07.836 -- 00:01:12.000 These forward-looking statements speak only as of today's ...